Cutler Group LP Adaptimmune Therapeutics PLC Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$0.43 - $0.79 $47 - $87	-111 Reduced 7.35%	1,400 $1,000
Q2 2023 Jul 18, 2023	BUY	$0.9 - $1.51 $1,359 - $2,281	1,511 New	1,511 $1,000
Q2 2022 Aug 04, 2022	SELL	$1.33 - $2.28 $133 - $227	-100 Reduced 20.0%	400 $0
Q1 2022 Apr 14, 2022	SELL	$1.73 - $4.06 $13,840 - $32,479	-8,000 Reduced 94.12%	500 $1,000
Q4 2021 Jan 18, 2022	BUY	$3.5 - $5.68 $25,550 - $41,464	7,300 Added 608.33%	8,500 $31,000
Q3 2021 Oct 26, 2021	BUY	$3.44 - $6.37 $2,408 - $4,459	700 Added 140.0%	1,200 $6,000
Q4 2020 Jan 21, 2021	SELL	$4.0 - $9.2 $10,400 - $23,919	-2,600 Reduced 83.87%	500 $2,000
Q3 2020 Oct 27, 2020	SELL	$7.66 - $10.78 $29,108 - $40,964	-3,800 Reduced 55.07%	3,100 $24,000
Q2 2020 Jul 22, 2020	BUY	$2.58 - $12.1 $10,836 - $50,820	4,200 Added 155.56%	6,900 $69,000
Q2 2019 Aug 09, 2019	SELL	$3.23 - $5.41 $1,615 - $2,705	-500 Reduced 15.63%	2,700 $10,000
Q4 2018 Feb 05, 2019	SELL	$3.76 - $14.16 $7,896 - $29,736	-2,100 Reduced 39.62%	3,200 $18,000
Q3 2018 Nov 07, 2018	BUY	$8.27 - $13.56 $5,789 - $9,492	700 Added 15.22%	5,300 $71,000
Q2 2018 Aug 10, 2018	BUY	$10.42 - $13.74 $44,806 - $59,082	4,300 Added 1433.33%	4,600 $54,000
Q4 2017 Jan 17, 2018	SELL	$6.68 - $8.74 $668 - $874	-100 Reduced 25.0%	300 $2,000
Q3 2017 Oct 17, 2017	BUY	$4.93 - $8.93 $1,972 - $3,572	400	400 $3,000

150M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $96.4M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.